Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
about
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidNeuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
P2860
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
@en
type
label
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
@en
prefLabel
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
@en
P2093
P2860
P356
P1433
P1476
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
@en
P2093
Kazuhide Hayakawa
Kenichi Mishima
Michihiro Fujiwara
P2860
P304
P356
10.3390/PH3072197
P577
2010-07-08T00:00:00Z